Today's Breaking News
- Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
- Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis